• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DIV
Click for more information
1.30% $1.14

Smartshares NZ Dividend ETF Units

watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DIV
Ann: DIV NTA 19-09-2024 $1.15127 		20/09/24 0 33
20/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  33 
DIV
Ann: Name Change - Smartshares Exchange Traded Funds 		20/09/24 0 23
20/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  23 
DIV
Ann: DIV NTA 18-09-2024 $1.15200 		19/09/24 0 29
19/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  29 
DIV
Ann: DIV NTA 17-09-2024 $1.15929 		18/09/24 0 34
18/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  34 
DIV
Ann: DIV NTA 16-09-2024 $1.16092 		17/09/24 0 46
17/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  46 
DIV
Ann: DIV NTA 13-09-2024 $1.17413 		16/09/24 0 42
16/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  42 
DIV
Ann: DIV NTA 12-09-2024 $1.17043 		13/09/24 0 40
13/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  40 
DIV
Ann: DIV NTA 11-09-2024 $1.15631 		12/09/24 0 50
12/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  50 

See All Discussions arrow Created with Sketch.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
(20min delay)
Last
$1.14 		Change
-0.015(1.30%) 		Mkt cap ! n/a
Open High Low Value Volume
$1.16 $1.16 $1.14 $88.85K 77.75K

Buyers (Bids)

No. Vol. Price($)
0 9 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.14 12782 0
Last trade - 12.59pm 20/09/2024 (20 minute delay) ?
DIV (NZSX) Chart

Top Stories

Tennant Minerals clocks high-grade gold, copper hits at Bluebird in the NT

Tennant Minerals has unveiled the results of its latest drill campaign at its Bluebird project, posting "high-grade" copper and gold hits.
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Westar wraps up field campaign at Mindoolah after divesting non-core assets ahead of 2025 Westar Resources (ASX:WSR) has wrapped up a field campaign on-site its Mindoolah Mining Centre project in WA.
Harvey Norman hit with a second class action – and shareholders, once again, don't care Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.